930782-89-1 Usage
Uses
Used in Pharmaceutical Industry:
(R)-4-BOC-1-CBZ-2-HYDROXYMETHYLPIPERAZINE is used as a chiral building block for the synthesis of pharmaceuticals, contributing to the development of enantiomerically pure compounds that are essential for the efficacy and safety of drugs. Its chiral properties allow for the creation of more effective and targeted medications.
Used in Agrochemical Industry:
In the agrochemical industry, (R)-4-BOC-1-CBZ-2-HYDROXYMETHYLPIPERAZINE is utilized as an intermediate in the synthesis of agrochemicals, helping to create more effective and environmentally friendly products for agricultural applications.
Used in Peptide and Oligonucleotide Synthesis:
(R)-4-BOC-1-CBZ-2-HYDROXYMETHYLPIPERAZINE is used as a key component in the synthesis of peptide and oligonucleotide derivatives, which are crucial for various biological and medical applications, including drug development, diagnostics, and therapeutics.
Used in Drug Development:
(R)-4-BOC-1-CBZ-2-HYDROXYMETHYLPIPERAZINE is employed in the development of new therapeutic agents for various medical conditions, leveraging its potential to contribute to the creation of innovative and effective treatments.
Used in Research and Development:
(R)-4-BOC-1-CBZ-2-HYDROXYMETHYLPIPERAZINE is also used in research and development settings to explore its potential applications and properties, furthering the understanding of its role in chemical synthesis and its implications for future pharmaceutical and agrochemical innovations.
Check Digit Verification of cas no
The CAS Registry Mumber 930782-89-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,0,7,8 and 2 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 930782-89:
(8*9)+(7*3)+(6*0)+(5*7)+(4*8)+(3*2)+(2*8)+(1*9)=191
191 % 10 = 1
So 930782-89-1 is a valid CAS Registry Number.
930782-89-1Relevant academic research and scientific papers
Pan-Tropic Entry Inhibitors
-
Page/Page column 38; 39, (2019/10/15)
This disclsore relates to compounds according to Formula (I), salts, prodrugs and pharmaceutical formulation comprising the compound are provided herein for the treatment of CXCR4 and CCR5 related conditions. The conditions may include viral infections, a
NOVEL AZETIDINE COMPOUNDS USEFUL IN THE TREATMENT OF FUNCTIONAL GASTROINTESTINAL DISORDERS, IBS AND FUNCTIONAL DYSPEPSIA
-
Page/Page column 47, (2008/06/13)
The present invention relates to new azetidine compounds, to pharmaceutical compositions cotaining them and the use of said compounds in in the treatment of functional gastrointestinal disorders, IBS and functional dyspepsia. The compounds are neurokinin
